8-K - BriaCell Therapeutics Corp. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

BriaCell Therapeutics Corp. held its Annual General and Special Meeting of security holders on March 5, 2026. The 8-K filing reports under Item 5.07 regarding submission of matters to a vote of security holders.

Key Takeaways

1Annual General and Special Meeting held on March 5, 2026

2Item 5.07: Submission of Matters to a Vote of Security Holders

Current Report Details

Event Type

Shareholder Vote

Disclosure

Mandatory

Variant

8-K

Items Reported

5.07

Submission of Matters to a Vote of Security Holders On March 5, 2026, BriaCell Therapeutics Corp. (the “Company”) held its Annual General and Special Meeting of

Shareholder Vote

Exhibits (1)

8-K